Bristol Laboratories Limited

Bristol Laboratories Limited, based in Berkhamsted, UK, is a large, holding company with an active status. Established 27 years ago in 1997, the company employs 477 people and holds assets valued at £41,074,590. It operates from a real address and is overseen by three directors and one owner. Bristol Laboratories is a regular importer of organic chemicals (557 months) and a regular exporter of pharmaceutical products (113 months).

The company's website showcases its focus on over-the-counter medicines, particularly through its brands Migraitan, Allacan, LemoCalm, and Ispagel. It specializes in manufacturing and delivering these medicines, targeting consumers seeking relief from common ailments. The site also caters to healthcare professionals, offering pharmacy training resources and information about the company’s OTC product range. It’s clearly aimed at UK residents only.

Financially, Bristol Laboratories Limited presents a mixed picture. While its assets remain substantial at £41,074,590, several key metrics have declined. Net assets dropped by 18% to £21,000,000, and bank borrowings increased by 25% to £1,000,000. Creditors decreased by 15%, suggesting improved debt management, but the decrease in net assets is a cause for concern. The company meets two of three criteria to be considered a large company: turnover more than £36 million and balance sheet total more than £18 million. The audit firm, King & King Chartered Accountants, conducted the audit.

The company’s focus on OTC medicines and its established brands suggest a stable business model, but the decline in net assets warrants closer scrutiny. The increased bank borrowings may indicate a need for additional capital, and the company’s ability to maintain its market position will depend on its ability to manage its finances effectively.

Registered in England/Wales under the registration number 03393503, with a registered address at HP4 1EG, Berkhamsted, Hertfordshire, Unit 3 Canalside, North Bridge Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.